About Solara Active Pharma Sciences Limited
Data last updated: 22 December 2025
Solara Active Pharma Sciences Limited is a public limited company based in Thane, Maharashtra, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 23 February 2017, the company has been in operation for over 9 years.
Registered with ROC Mumbai under CIN U24230MH2017PLC291636. Listed on BSE: 541540 and NSE: SOLARA.
Capital: an authorised share capital of ₹120 Cr and a paid-up capital of ₹44.49 Cr. Formerly known as Ssl Pharma Sciences Limited. It is led by directors including Poorvank Purohit and Rajiv Vijay Nabar.
Last AGM: 25 September 2025. Financial statements filed for year ended 31 March 2025. Office: Sector 30, Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,292.08 Cr, a growth of 0% compared to the previous year.
The company has a workforce of approximately 1,656 employees as per the latest available data.
The company is associated with 1 brand - Solara Active Pharma Sciences. As per MCA filings, the company has open charges of ₹1,799.4 Cr and satisfied charges of ₹2,310.69 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website solara.co.in.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media**************
-
Registered AddressCyber One Unit No. 902 Sector 30A, Plot No. 4 & 6 Vashi Navi Mumbai, Thane, Maharashtra, India – 400703
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited has one previous CIN (Corporate Identification Number): U24230MH2017PLC291636. The current CIN is L24230MH2017PLC291636, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24230MH2017PLC291636 | Current |
| U24230MH2017PLC291636 | Previous |
Associated Brands with Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited operates one associated brand: Solara Active Pharma Sciences. These brands represent Solara Active Pharma Sciences Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| APIs and intermediates are manufactured for therapeutic categories. | solara.co.in |
Business Activity of Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | ********* |
Auditor Details of Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited is audited by Delloitte Haskins & Sells LLP (ICAI peer reviewed, certificate valid till 2027-07-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| Delloitte Haskins & Sells LLP (ICAI peer reviewed, certificate valid till 2027-07-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited is currently managed by 12 directors, with 24 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Poorvank Purohit | Managing Director | 05 Jul 2023 | 3 Years 0 Months | Current |
|
Rajiv Vijay Nabar
Also directs:
Tac Infosec Limited, Veegen Diet Care Private Limited
|
Director | 14 Nov 2023 | 2 Years 7 Months | Current |
| Ramakrishnan Rajagopal | Director | 11 Apr 2018 | 8 Years 2 Months | Current |
| Mohanraj Sanjeevi | Additional Director | 01 Jan 2026 | 0 Years 6 Months | Current |
| Manish Gupta | Director | 22 Jul 2024 | 1 Years 11 Months | Current |
| Rajendra Kumar Srivastava | Director | 14 Nov 2023 | 2 Years 7 Months | Current |
Financials of Solara Active Pharma Sciences Limited FY 2026 filings available
Solara Active Pharma Sciences Limited reported revenue of ₹1,368.98 Cr (up 6.64% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹1,368.98 Cr | ₹1,283.76 Cr | ₹1,288.92 Cr | ₹1,443.81 Cr | ₹1,268.34 Cr | ₹1,616.88 Cr | ₹1,321.75 Cr |
| Other Income | ₹6.16 Cr | ₹8.32 Cr | ₹5.37 Cr | ₹22.55 Cr | ₹20.02 Cr | ₹28.77 Cr | ₹27.52 Cr |
| Total Income | ₹1,375.14 Cr | ₹1,292.08 Cr | ₹1,294.29 Cr | ₹1,466.36 Cr | ₹1,288.36 Cr | ₹1,645.65 Cr | ₹1,349.27 Cr |
| Cost of Materials Consumed | ₹672.77 Cr | ₹581.66 Cr | ₹760.65 Cr | ₹773.89 Cr | ₹858.86 Cr | ₹683.77 Cr | ₹602.15 Cr |
| Purchases of Stock-in-Trade | ₹3.49 Cr | ₹5.75 Cr | ₹5.1 Cr | ₹7.88 Cr | ₹53.78 Cr | ₹42.8 Cr | ₹29.67 Cr |
| Changes in Inventories | ₹8.25 Cr | ₹39 Cr | ₹39.27 Cr | ₹7.05 Cr | -₹258.75 Cr | -₹2.15 Cr | -₹32.95 Cr |
| Employee Benefit Expense | ₹219.2 Cr | ₹211.69 Cr | ₹243.92 Cr | ₹228.63 Cr | ₹236.34 Cr | ₹229.37 Cr | ₹204.13 Cr |
| Finance Costs | ₹94.75 Cr | ₹114.81 Cr | ₹105.11 Cr | ₹90.06 Cr | ₹75.28 Cr | ₹84.48 Cr | ₹77.89 Cr |
| Depreciation & Amortisation | ₹99.68 Cr | ₹99.25 Cr | ₹103.33 Cr | ₹111.19 Cr | ₹112.32 Cr | ₹108.66 Cr | ₹94.16 Cr |
| Other Expenses | ₹278.52 Cr | ₹239.38 Cr | ₹335.16 Cr | ₹292.47 Cr | ₹298.14 Cr | ₹277.22 Cr | ₹259.31 Cr |
| Total Expenses | ₹1,376.66 Cr | ₹1,291.54 Cr | ₹1,592.54 Cr | ₹1,511.17 Cr | ₹1,375.97 Cr | ₹1,424.15 Cr | ₹1,234.36 Cr |
| Profit Before Exceptional Items & Tax | -₹1.52 Cr | ₹54 Lakh | -₹298.25 Cr | -₹44.81 Cr | -₹87.61 Cr | ₹221.5 Cr | ₹114.91 Cr |
| Exceptional Items | -₹5.89 Cr | ₹0 | -₹190.17 Cr | ₹0 | -₹3.49 Cr | ₹0 | ₹0 |
| Profit Before Tax | -₹7.41 Cr | ₹54 Lakh | -₹488.42 Cr | -₹44.81 Cr | -₹91.1 Cr | ₹221.5 Cr | ₹114.91 Cr |
| Total Tax Expense | ₹0 | ₹0 | ₹78.54 Cr | -₹22.57 Cr | -₹32.81 Cr | ₹15 Lakh | ₹39 Lakh |
| Net Profit | -₹7.41 Cr | ₹54 Lakh | -₹566.96 Cr | -₹22.24 Cr | -₹58.29 Cr | ₹221.35 Cr | ₹114.52 Cr |
| attributable to Owners | -₹7.41 Cr | ₹54 Lakh | -₹567.39 Cr | -₹22.17 Cr | -₹58.15 Cr | ₹221.4 Cr | ₹110.9 Cr |
| attributable to NCI | ₹0 | -₹10,000 | ₹43 Lakh | -₹7 Lakh | -₹14 Lakh | -₹5 Lakh | -₹9 Lakh |
| Other Comprehensive Income | ₹2.85 Cr | ₹98 Lakh | ₹49 Lakh | -₹2.06 Cr | ₹1.89 Cr | -₹2.4 Cr | -₹3.71 Cr |
| Total Comprehensive Income | -₹4.56 Cr | ₹1.52 Cr | -₹566.47 Cr | -₹24.3 Cr | -₹56.4 Cr | ₹218.95 Cr | ₹110.81 Cr |
| EBITDA (computed) | ₹192.91 Cr | ₹214.6 Cr | -₹89.81 Cr | ₹156.44 Cr | ₹99.99 Cr | ₹414.64 Cr | ₹286.96 Cr |
| Basic EPS | ₹-1.68 | ₹0.14 | ₹-157.62 | ₹-6.16 | ₹-16.18 | ₹69.00 | ₹44.29 |
| Diluted EPS | ₹-1.68 | ₹0.14 | ₹-157.62 | ₹-6.16 | ₹-16.18 | ₹64.52 | ₹42.82 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹2,332.59 Cr | ₹2,231.84 Cr | ₹2,350.96 Cr | ₹2,899.06 Cr |
| Non-current Assets | ₹1,474.49 Cr | ₹1,503.11 Cr | ₹1,550.21 Cr | ₹1,711.74 Cr |
| Current Assets | ₹858.1 Cr | ₹728.73 Cr | ₹788.07 Cr | ₹1,187.32 Cr |
| Property, Plant & Equipment | ₹793.18 Cr | ₹738.68 Cr | ₹857.85 Cr | ₹920.58 Cr |
| Inventories | ₹317.87 Cr | ₹317.9 Cr | ₹359.7 Cr | ₹558.09 Cr |
| Trade Receivables | ₹438.72 Cr | ₹326.57 Cr | ₹348.52 Cr | ₹536.99 Cr |
| Cash & Equivalents | ₹4.48 Cr | ₹3.95 Cr | ₹8.44 Cr | ₹8.73 Cr |
| Equity (Net Worth) | ₹1,255.55 Cr | ₹1,096.91 Cr | ₹936.58 Cr | ₹1,502.46 Cr |
| Equity Share Capital | ₹44.51 Cr | ₹40.25 Cr | ₹36 Cr | ₹36 Cr |
| Borrowings (Non-current) | ₹110.45 Cr | ₹113.86 Cr | ₹105.83 Cr | ₹235.1 Cr |
| Borrowings (Current) | ₹554.09 Cr | ₹662.2 Cr | ₹894.06 Cr | ₹766.05 Cr |
| Total Debt (computed) | ₹664.54 Cr | ₹776.06 Cr | ₹999.89 Cr | ₹1,001.15 Cr |
| Current Liabilities | ₹893.91 Cr | ₹944.11 Cr | ₹1,242.79 Cr | ₹1,100.9 Cr |
| Total Liabilities | ₹1,077.04 Cr | ₹1,134.93 Cr | ₹1,414.38 Cr | ₹1,396.6 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹152.91 Cr | ₹212.82 Cr | ₹108.87 Cr | ₹156.25 Cr | -₹242.09 Cr |
| Investing Cash Flow | -₹98.83 Cr | -₹36.83 Cr | -₹3.51 Cr | -₹81.14 Cr | -₹242.82 Cr |
| Financing Cash Flow | -₹53.55 Cr | -₹180.48 Cr | -₹105.65 Cr | -₹112.76 Cr | ₹333.6 Cr |
| Capital Expenditure | ₹52.82 Cr | ₹39.94 Cr | ₹41.06 Cr | ₹111.31 Cr | ₹208.59 Cr |
| Free Cash Flow (computed) | ₹100.09 Cr | ₹172.88 Cr | ₹67.81 Cr | ₹44.94 Cr | -₹450.68 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹10.78 Cr |
| Net Change in Cash | ₹53 Lakh | -₹4.49 Cr | -₹29 Lakh | -₹37.65 Cr | -₹151.31 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹387.29 Cr | ₹349 Cr | ₹313.54 Cr | ₹319.15 Cr | ₹273.01 Cr | ₹300.31 Cr | ₹346.95 Cr | ₹363.49 Cr | ₹299.43 Cr | ₹248.73 Cr | ₹425.24 Cr | ₹352.31 Cr |
| Other Income | ₹4.69 Cr | ₹0 | ₹49 Lakh | ₹98 Lakh | ₹5.95 Cr | ₹1.49 Cr | ₹32 Lakh | ₹56 Lakh | ₹1.7 Cr | ₹45 Lakh | ₹1.18 Cr | ₹2.04 Cr |
| Total Income | ₹391.98 Cr | ₹349 Cr | ₹314.03 Cr | ₹320.13 Cr | ₹278.96 Cr | ₹301.8 Cr | ₹347.27 Cr | ₹364.05 Cr | ₹301.13 Cr | ₹249.18 Cr | ₹426.42 Cr | ₹354.35 Cr |
| Cost of Materials Consumed | ₹182.23 Cr | ₹175.71 Cr | ₹149.69 Cr | ₹165.14 Cr | ₹143.67 Cr | ₹143.96 Cr | ₹156.93 Cr | ₹137.1 Cr | ₹158.38 Cr | ₹157.76 Cr | ₹241.83 Cr | ₹202.68 Cr |
| Purchases of Stock-in-Trade | ₹77 Lakh | ₹2.72 Cr | ₹0 | ₹0 | ₹5.05 Cr | ₹0 | ₹70 Lakh | ₹0 | ₹15 Lakh | ₹25 Lakh | ₹3.12 Cr | ₹1.58 Cr |
| Changes in Inventories | ₹14.44 Cr | ₹8.17 Cr | ₹4.31 Cr | -₹18.67 Cr | -₹30.63 Cr | -₹9.1 Cr | ₹14.26 Cr | ₹64.47 Cr | ₹1.45 Cr | ₹57.51 Cr | -₹7.42 Cr | -₹12.27 Cr |
| Employee Benefit Expense | ₹55.47 Cr | ₹55.23 Cr | ₹54.86 Cr | ₹53.64 Cr | ₹52.29 Cr | ₹51.67 Cr | ₹52.71 Cr | ₹55.02 Cr | ₹56.01 Cr | ₹62.64 Cr | ₹64.12 Cr | ₹61.15 Cr |
| Finance Costs | ₹27.57 Cr | ₹22.45 Cr | ₹20.83 Cr | ₹23.9 Cr | ₹29.12 Cr | ₹26.54 Cr | ₹28.28 Cr | ₹30.87 Cr | ₹30.69 Cr | ₹25.37 Cr | ₹24.44 Cr | ₹24.61 Cr |
| Depreciation & Amortisation | ₹26.04 Cr | ₹25.57 Cr | ₹24.49 Cr | ₹23.58 Cr | ₹24.3 Cr | ₹24.54 Cr | ₹25.34 Cr | ₹25.07 Cr | ₹25.25 Cr | ₹25.96 Cr | ₹26.21 Cr | ₹25.91 Cr |
| Other Expenses | ₹76.72 Cr | ₹69.83 Cr | ₹69.95 Cr | ₹62.02 Cr | ₹57.26 Cr | ₹56.1 Cr | ₹61.04 Cr | ₹64.98 Cr | ₹73.68 Cr | ₹132.26 Cr | ₹85.96 Cr | ₹80.05 Cr |
| Total Expenses | ₹383.24 Cr | ₹359.68 Cr | ₹324.13 Cr | ₹309.61 Cr | ₹281.06 Cr | ₹293.71 Cr | ₹339.26 Cr | ₹377.51 Cr | ₹345.61 Cr | ₹461.75 Cr | ₹438.26 Cr | ₹383.71 Cr |
| Profit Before Exceptional Items & Tax | ₹8.74 Cr | -₹10.68 Cr | -₹10.1 Cr | ₹10.52 Cr | -₹2.1 Cr | ₹8.09 Cr | ₹8.01 Cr | -₹13.46 Cr | -₹44.48 Cr | -₹212.57 Cr | -₹11.84 Cr | -₹29.36 Cr |
| Exceptional Items | ₹86 Lakh | -₹6.75 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | -₹122.18 Cr | -₹62.77 Cr | -₹5.22 Cr | ₹0 |
| Profit Before Tax | ₹9.6 Cr | -₹17.43 Cr | -₹10.1 Cr | ₹10.52 Cr | -₹2.1 Cr | ₹8.09 Cr | ₹8.01 Cr | -₹13.46 Cr | -₹166.66 Cr | -₹275.34 Cr | -₹17.06 Cr | -₹29.36 Cr |
| Total Tax Expense | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹88.79 Cr | ₹0 | ₹0 | -₹10.25 Cr |
| Net Profit | ₹9.6 Cr | -₹17.43 Cr | -₹10.1 Cr | ₹10.52 Cr | -₹2.1 Cr | ₹8.09 Cr | ₹8.01 Cr | -₹13.46 Cr | -₹255.45 Cr | -₹275.34 Cr | -₹17.06 Cr | -₹19.11 Cr |
| attributable to Owners | ₹9.6 Cr | -₹17.43 Cr | -₹10.1 Cr | ₹10.52 Cr | -₹2.1 Cr | ₹8.09 Cr | - | -₹13.47 Cr | -₹255.34 Cr | -₹275.34 Cr | -₹17.16 Cr | -₹19.55 Cr |
| attributable to NCI | ₹0 | ₹0 | ₹0 | ₹0 | -₹10,000 | ₹0 | - | ₹0 | -₹11 Lakh | ₹0 | ₹10 Lakh | ₹44 Lakh |
| Other Comprehensive Income | ₹50 Lakh | ₹1.55 Cr | ₹81 Lakh | -₹1 Lakh | -₹62 Lakh | -₹7 Lakh | ₹1.68 Cr | -₹1 Lakh | ₹30 Lakh | -₹4 Lakh | ₹23 Lakh | ₹0 |
| Total Comprehensive Income | ₹10.1 Cr | -₹15.88 Cr | -₹9.29 Cr | ₹10.51 Cr | -₹2.72 Cr | ₹8.02 Cr | ₹9.69 Cr | -₹13.47 Cr | -₹255.15 Cr | -₹275.38 Cr | -₹16.83 Cr | -₹19.11 Cr |
| EBITDA (computed) | ₹62.35 Cr | ₹37.34 Cr | ₹35.22 Cr | ₹58 Cr | ₹51.32 Cr | ₹59.17 Cr | ₹61.63 Cr | ₹42.48 Cr | ₹11.46 Cr | -₹161.24 Cr | ₹38.81 Cr | ₹21.16 Cr |
| Basic EPS | ₹2.20 | ₹-3.98 | ₹-2.36 | ₹2.46 | ₹-0.93 | ₹2.03 | ₹2.54 | ₹-3.50 | ₹-70.93 | ₹-76.49 | ₹-4.77 | ₹-5.43 |
| Diluted EPS | ₹2.20 | ₹-3.98 | ₹-2.36 | ₹2.46 | ₹-0.93 | ₹2.03 | ₹2.54 | ₹-3.50 | ₹-70.93 | ₹-76.49 | ₹-4.77 | ₹-5.43 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹1,368.98 Cr | ₹1,283.76 Cr | ₹1,288.92 Cr | ₹1,443.81 Cr | ₹1,268.34 Cr | ₹1,616.88 Cr | ₹1,321.75 Cr |
| Other Income | ₹5.89 Cr | ₹9.14 Cr | ₹5.37 Cr | ₹22.14 Cr | ₹18.76 Cr | ₹28.41 Cr | ₹27.51 Cr |
| Total Income | ₹1,374.87 Cr | ₹1,292.9 Cr | ₹1,294.29 Cr | ₹1,465.95 Cr | ₹1,287.1 Cr | ₹1,645.29 Cr | ₹1,349.26 Cr |
| Cost of Materials Consumed | ₹672.77 Cr | ₹581.66 Cr | ₹760.66 Cr | ₹773.9 Cr | ₹858.86 Cr | ₹683.76 Cr | ₹602.15 Cr |
| Purchases of Stock-in-Trade | ₹3.49 Cr | ₹5.75 Cr | ₹5.1 Cr | ₹7.88 Cr | ₹53.78 Cr | ₹42.8 Cr | ₹29.67 Cr |
| Changes in Inventories | ₹8.25 Cr | ₹39 Cr | ₹39.27 Cr | ₹7.05 Cr | -₹258.75 Cr | -₹2.15 Cr | -₹32.95 Cr |
| Employee Benefit Expense | ₹219.2 Cr | ₹211.68 Cr | ₹243.92 Cr | ₹228.05 Cr | ₹234.2 Cr | ₹227.63 Cr | ₹202.24 Cr |
| Finance Costs | ₹94.24 Cr | ₹114.81 Cr | ₹105.97 Cr | ₹90.06 Cr | ₹75.27 Cr | ₹84.47 Cr | ₹77.88 Cr |
| Depreciation & Amortisation | ₹99.68 Cr | ₹99.25 Cr | ₹103.03 Cr | ₹110.9 Cr | ₹112.01 Cr | ₹108.31 Cr | ₹93.67 Cr |
| Other Expenses | ₹278.59 Cr | ₹241.83 Cr | ₹335.04 Cr | ₹292.89 Cr | ₹299.9 Cr | ₹279.51 Cr | ₹264.11 Cr |
| Total Expenses | ₹1,376.22 Cr | ₹1,293.98 Cr | ₹1,592.99 Cr | ₹1,510.73 Cr | ₹1,375.27 Cr | ₹1,424.33 Cr | ₹1,236.77 Cr |
| Profit Before Exceptional Items & Tax | -₹1.35 Cr | -₹1.08 Cr | -₹298.7 Cr | -₹44.78 Cr | -₹88.17 Cr | ₹220.96 Cr | ₹112.49 Cr |
| Exceptional Items | -₹5.89 Cr | ₹0 | -₹189.64 Cr | ₹0 | -₹3.49 Cr | ₹0 | ₹0 |
| Profit Before Tax | -₹7.24 Cr | -₹1.08 Cr | -₹488.34 Cr | -₹44.78 Cr | -₹91.66 Cr | ₹220.96 Cr | ₹112.49 Cr |
| Total Tax Expense | ₹0 | ₹0 | ₹78.54 Cr | -₹22.57 Cr | -₹33.1 Cr | ₹0 | ₹0 |
| Net Profit | -₹7.24 Cr | -₹1.08 Cr | -₹566.88 Cr | -₹22.21 Cr | -₹58.56 Cr | ₹220.96 Cr | ₹112.49 Cr |
| Other Comprehensive Income | ₹3.27 Cr | ₹1.06 Cr | ₹56 Lakh | -₹1.76 Cr | ₹2.01 Cr | -₹2.53 Cr | -₹3.29 Cr |
| Total Comprehensive Income | -₹3.97 Cr | -₹2 Lakh | -₹566.32 Cr | -₹23.97 Cr | -₹56.55 Cr | ₹218.43 Cr | ₹109.2 Cr |
| EBITDA (computed) | ₹192.57 Cr | ₹212.98 Cr | -₹89.7 Cr | ₹156.18 Cr | ₹99.11 Cr | ₹413.74 Cr | ₹284.04 Cr |
| Basic EPS | ₹-1.64 | ₹-0.27 | ₹-157.48 | ₹-6.17 | ₹-16.29 | ₹68.86 | ₹43.47 |
| Diluted EPS | ₹-1.64 | ₹-0.27 | ₹-157.48 | ₹-6.17 | ₹-16.29 | ₹64.40 | ₹42.03 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Total Assets | ₹2,276.59 Cr | ₹2,225.1 Cr | ₹2,346.6 Cr | ₹2,894.95 Cr |
| Non-current Assets | ₹1,467.9 Cr | ₹1,496.5 Cr | ₹1,555.95 Cr | ₹1,704.08 Cr |
| Current Assets | ₹808.69 Cr | ₹728.6 Cr | ₹790.65 Cr | ₹1,190.87 Cr |
| Property, Plant & Equipment | ₹786.58 Cr | ₹732.08 Cr | ₹851.24 Cr | ₹913.97 Cr |
| Inventories | ₹317.87 Cr | ₹317.9 Cr | ₹359.7 Cr | ₹558.09 Cr |
| Trade Receivables | ₹438.87 Cr | ₹326.57 Cr | ₹351.22 Cr | ₹539.65 Cr |
| Cash & Equivalents | ₹4 Cr | ₹3.81 Cr | ₹8.32 Cr | ₹8.55 Cr |
| Equity (Net Worth) | ₹1,255.44 Cr | ₹1,096.21 Cr | ₹937.42 Cr | ₹1,503.13 Cr |
| Equity Share Capital | ₹44.51 Cr | ₹40.25 Cr | ₹36 Cr | ₹36 Cr |
| Borrowings (Non-current) | ₹60.94 Cr | ₹113.86 Cr | ₹105.83 Cr | ₹235.1 Cr |
| Borrowings (Current) | ₹554.09 Cr | ₹662.2 Cr | ₹893.55 Cr | ₹766.05 Cr |
| Total Debt (computed) | ₹615.03 Cr | ₹776.06 Cr | ₹999.38 Cr | ₹1,001.15 Cr |
| Current Liabilities | ₹887.53 Cr | ₹938.07 Cr | ₹1,237.65 Cr | ₹1,096.12 Cr |
| Total Liabilities | ₹1,021.15 Cr | ₹1,128.89 Cr | ₹1,409.18 Cr | ₹1,391.82 Cr |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹152.89 Cr | ₹212.8 Cr | ₹110.95 Cr | ₹156.17 Cr | -₹241.79 Cr |
| Investing Cash Flow | -₹50.14 Cr | -₹36.83 Cr | -₹4.66 Cr | -₹81.13 Cr | -₹243.07 Cr |
| Financing Cash Flow | -₹102.56 Cr | -₹180.48 Cr | -₹106.52 Cr | -₹112.76 Cr | ₹333.6 Cr |
| Capital Expenditure | ₹52.82 Cr | ₹39.94 Cr | ₹43.07 Cr | ₹111.31 Cr | ₹208.86 Cr |
| Free Cash Flow (computed) | ₹100.07 Cr | ₹172.86 Cr | ₹67.88 Cr | ₹44.86 Cr | -₹450.65 Cr |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹10.78 Cr |
| Net Change in Cash | ₹19 Lakh | -₹4.51 Cr | -₹23 Lakh | -₹37.72 Cr | -₹151.26 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q4 FY24 | Q3 FY24 | Q2 FY24 | Q1 FY24 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹387.29 Cr | ₹349 Cr | ₹313.54 Cr | ₹319.15 Cr | ₹273.01 Cr | ₹300.31 Cr | ₹346.95 Cr | ₹363.49 Cr | ₹299.43 Cr | ₹248.73 Cr | ₹425.24 Cr | ₹352.31 Cr |
| Other Income | ₹4.42 Cr | ₹0 | ₹49 Lakh | ₹98 Lakh | ₹5.95 Cr | ₹1.49 Cr | ₹32 Lakh | ₹1.38 Cr | ₹1.63 Cr | ₹44 Lakh | ₹1.23 Cr | ₹2.07 Cr |
| Total Income | ₹391.71 Cr | ₹349 Cr | ₹314.03 Cr | ₹320.13 Cr | ₹278.96 Cr | ₹301.8 Cr | ₹347.27 Cr | ₹364.87 Cr | ₹301.06 Cr | ₹249.17 Cr | ₹426.47 Cr | ₹354.38 Cr |
| Cost of Materials Consumed | ₹182.23 Cr | ₹175.71 Cr | ₹149.69 Cr | ₹165.14 Cr | ₹143.67 Cr | ₹143.96 Cr | ₹156.93 Cr | ₹137.1 Cr | ₹158.39 Cr | ₹157.76 Cr | ₹241.83 Cr | ₹202.68 Cr |
| Purchases of Stock-in-Trade | ₹77 Lakh | ₹2.72 Cr | ₹0 | ₹0 | ₹5.05 Cr | ₹0 | ₹70 Lakh | ₹0 | ₹15 Lakh | ₹25 Lakh | ₹3.12 Cr | ₹1.58 Cr |
| Changes in Inventories | ₹14.44 Cr | ₹8.17 Cr | ₹4.31 Cr | -₹18.67 Cr | -₹30.63 Cr | -₹9.1 Cr | ₹14.26 Cr | ₹64.47 Cr | ₹1.45 Cr | ₹57.51 Cr | -₹7.42 Cr | -₹12.27 Cr |
| Employee Benefit Expense | ₹55.47 Cr | ₹55.23 Cr | ₹54.86 Cr | ₹53.64 Cr | ₹52.28 Cr | ₹51.67 Cr | ₹52.71 Cr | ₹55.02 Cr | ₹56.01 Cr | ₹62.64 Cr | ₹64.12 Cr | ₹61.15 Cr |
| Finance Costs | ₹27.06 Cr | ₹22.45 Cr | ₹20.83 Cr | ₹23.9 Cr | ₹29.12 Cr | ₹26.54 Cr | ₹28.28 Cr | ₹30.87 Cr | ₹30.62 Cr | ₹25.37 Cr | ₹24.47 Cr | ₹25.51 Cr |
| Depreciation & Amortisation | ₹26.04 Cr | ₹25.57 Cr | ₹24.49 Cr | ₹23.58 Cr | ₹24.3 Cr | ₹24.54 Cr | ₹25.34 Cr | ₹25.07 Cr | ₹25.1 Cr | ₹25.96 Cr | ₹26.14 Cr | ₹25.83 Cr |
| Other Expenses | ₹76.83 Cr | ₹69.82 Cr | ₹69.93 Cr | ₹62.01 Cr | ₹60.05 Cr | ₹56.09 Cr | ₹61.03 Cr | ₹64.66 Cr | ₹73.64 Cr | ₹132.24 Cr | ₹85.92 Cr | ₹80.03 Cr |
| Total Expenses | ₹382.84 Cr | ₹359.67 Cr | ₹324.11 Cr | ₹309.6 Cr | ₹283.84 Cr | ₹293.7 Cr | ₹339.25 Cr | ₹377.19 Cr | ₹345.36 Cr | ₹461.73 Cr | ₹438.18 Cr | ₹384.51 Cr |
| Profit Before Exceptional Items & Tax | ₹8.87 Cr | -₹10.67 Cr | -₹10.08 Cr | ₹10.53 Cr | -₹4.88 Cr | ₹8.1 Cr | ₹8.02 Cr | -₹12.32 Cr | -₹44.3 Cr | -₹212.56 Cr | -₹11.71 Cr | -₹30.13 Cr |
| Exceptional Items | ₹86 Lakh | -₹6.75 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | -₹123.32 Cr | -₹62.77 Cr | -₹3.55 Cr | ₹0 |
| Profit Before Tax | ₹9.73 Cr | -₹17.42 Cr | -₹10.08 Cr | ₹10.53 Cr | -₹4.88 Cr | ₹8.1 Cr | ₹8.02 Cr | -₹12.32 Cr | -₹167.62 Cr | -₹275.33 Cr | -₹15.26 Cr | -₹30.13 Cr |
| Total Tax Expense | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹88.79 Cr | ₹0 | ₹0 | -₹10.25 Cr |
| Net Profit | ₹9.73 Cr | -₹17.42 Cr | -₹10.08 Cr | ₹10.53 Cr | -₹4.88 Cr | ₹8.1 Cr | ₹8.02 Cr | -₹12.32 Cr | -₹256.41 Cr | -₹275.33 Cr | -₹15.26 Cr | -₹19.88 Cr |
| Other Comprehensive Income | ₹71 Lakh | ₹1.6 Cr | ₹96 Lakh | ₹0 | -₹64 Lakh | ₹0 | ₹1.7 Cr | ₹0 | ₹32 Lakh | ₹0 | ₹24 Lakh | ₹0 |
| Total Comprehensive Income | ₹10.44 Cr | -₹15.82 Cr | -₹9.12 Cr | ₹10.53 Cr | -₹5.52 Cr | ₹8.1 Cr | ₹9.72 Cr | -₹12.32 Cr | -₹256.09 Cr | -₹275.33 Cr | -₹15.02 Cr | -₹19.88 Cr |
| EBITDA (computed) | ₹61.97 Cr | ₹37.35 Cr | ₹35.24 Cr | ₹58.01 Cr | ₹48.54 Cr | ₹59.18 Cr | ₹61.64 Cr | ₹43.62 Cr | ₹11.42 Cr | -₹161.23 Cr | ₹38.9 Cr | ₹21.21 Cr |
| Basic EPS | ₹2.23 | ₹-3.97 | ₹-2.36 | ₹2.46 | ₹-1.65 | ₹2.47 | ₹2.11 | ₹-3.20 | ₹-71.23 | ₹-76.49 | ₹-4.24 | ₹-5.52 |
| Diluted EPS | ₹2.23 | ₹-3.97 | ₹-2.36 | ₹2.46 | ₹-1.65 | ₹2.47 | ₹2.11 | ₹-3.20 | ₹-71.23 | ₹-76.49 | ₹-4.24 | ₹-5.52 |
Board & Governance of Solara Active Pharma Sciences Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Solara Active Pharma Sciences Limited has 8 directors - 4 independent and 2 executive. The board is chaired by Ramakrishnan Rajagopal.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Ramakrishnan Rajagopal | Non-Executive - Independent Director · Chairperson | 2018-04-11 | 1 |
| Kausalya Santhanam | Non-Executive - Independent Director | 2018-04-11 | 2 |
| Arun Kumar Pillai | Non-Executive - Non Independent Director | 2021-08-04 | 3 |
| Sandeep Shashikantha Rao | Executive Director · CEO-MD | 2025-02-21 | 1 |
| Manish Gupta | Non-Executive - Non Independent Director | 2024-07-22 | 2 |
| Rajendra Kumar Srivastava | Non-Executive - Independent Director | 2023-11-14 | 2 |
| Rajiv Vijay Nabar | Non-Executive - Independent Director | 2023-11-14 | 2 |
| Mohanraj Sanjeevi | Executive Director | 2026-01-01 | 1 |
| Committee | Members |
|---|---|
| Audit Committee | Ramakrishnan Rajagopal (Chairperson), Kausalya Santhanam, Rajendra Kumar Srivastava, Rajiv Vijay Nabar |
| Nomination and remuneration committee | Rajendra Kumar Srivastava (Chairperson), Kausalya Santhanam, Rajiv Vijay Nabar, Ramakrishnan Rajagopal |
| Stakeholders Relationship Committee | Kausalya Santhanam (Chairperson), Sandeep Shashikantha Rao, Manish Gupta |
| Risk Management Committee | Rajiv Vijay Nabar (Chairperson), Kausalya Santhanam, Rajendra Kumar Srivastava, Ramakrishnan Rajagopal, Sandeep Shashikantha Rao |
| Corporate Social Responsibility Committee | Kausalya Santhanam (Chairperson), Ramakrishnan Rajagopal, Sandeep Shashikantha Rao |
Charges & Borrowings of Solara Active Pharma Sciences Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jan 2025 | Others | ₹75 Cr | Open |
| 28 Sep 2022 | Yes Bank Limited | ₹65 Cr | Open |
| 28 Sep 2022 | Yes Bank Limited | ₹75 Cr | Open |
| 22 Nov 2021 | Others | ₹150 Cr | Open |
| 21 Jan 2021 | Others | ₹170 Cr | Open |
Total charge records: 26 View all charges
Employees and EPFO Compliance at Solara Active Pharma Sciences Limited
View historical data on people associated with Solara Active Pharma Sciences Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Solara Active Pharma Sciences Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Solara Active Pharma Sciences Limited
GSTIN & GST Filing Data of Solara Active Pharma Sciences Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Solara Active Pharma Sciences Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Solara Active Pharma Sciences Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Solara Active Pharma Sciences Limited
MSME Payment Delays by Solara Active Pharma Sciences Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Solara Active Pharma Sciences Limited
Subsidiaries & Group Companies of Solara Active Pharma Sciences Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Solara Active Pharma Sciences Limited with ownership details.
MCA Filings & Documents of Solara Active Pharma Sciences Limited
MCA Filings & Documents of Solara Active Pharma Sciences Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Solara Active Pharma Sciences Limited
Recent News on Solara Active Pharma Sciences Limited
Frequently Asked Questions about Solara Active Pharma Sciences Limited
Solara Active Pharma Sciences Limited is an active public limited company in the pharma sector based in Thane, Maharashtra, India. It was incorporated on 23 February 2017 (9+ years old) and is registered under CIN L24230MH2017PLC291636. Listed on BSE: 541540 and NSE: SOLARA. The company has 1,656 employees.
Solara Active Pharma Sciences Limited reported revenue of ₹1,292.08 Cr for FY 2025 (up 0.00% YoY).
The current directors of Solara Active Pharma Sciences Limited are:
- Poorvank Purohit
- Rajiv Vijay Nabar
- Ramakrishnan Rajagopal
- Mohanraj Sanjeevi
- Poorvank Purohit
- Suddapalli Muralikrishna
- Manish Gupta
- Rajendra Kumar Srivastava
- Kausalya Santhanam
- Arun Kumar Pillai
- Sandeep Shashikantha Rao
- Sarat Kumar Asuri
The primary industry of Solara Active Pharma Sciences Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Yes. Solara Active Pharma Sciences Limited is listed on both BSE (code: 541540) and NSE (symbol: SOLARA).
Solara Active Pharma Sciences Limited can be reached at the registered office: Cyber One Unit No. 902 Sector 30A, Plot No. 4 & 6 Vashi Navi Mumbai, Thane, Maharashtra, India – 400703, or through the website solara.co.in.